Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 110

Showing 26-50 of 110 citing articles:

Antioxidant effect of Pyhllanthus niruri and Catharanthus roseus combination extract on breast cancer mice models
Sefihara Paramitha Sakti, Fikriya Novita Sari, Farida Rachmawati, et al.
AIP conference proceedings (2025) Vol. 3253, pp. 020021-020021
Closed Access
Nrf2 Ameliorates Sevoflurane-Induced Cognitive Deficits in Aged Mice by Inhibiting Neuroinflammation in the Hippocampus
Junhua Li, Jinfeng Li, Yafang Liu, et al.
Molecular Neurobiology (2025)
Closed Access
Kwas Karnozynowy w Nowotworzeniu: od Teorii do Praktyki
Magdalena Wojtczuk, Agnieszka Dominiak
Prospects in Pharmaceutical Sciences (2025) Vol. 23, Iss. 1, pp. 80-88
Open Access
Overview of Nrf2 as a target in ovary and ovarian dysfunctions focusing on its antioxidant properties
Taha Ghantabpour, Nasim Goudarzi, Houman Parsaie
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
NRF2 Antioxidant Cellular System as a Therapeutic Target for Enhancing Cancer Radiosensitivity
G. G. Golyshev, K. V. Tikunova, O. A. Zaytsev, et al.
Meditsinskaya Fizika (2025), Iss. 1, pp. 94-109
Closed Access
miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism
Megharani Mahajan, Sandhya L. Sitasawad
Cells (2021) Vol. 11, Iss. 1, pp. 12-12
Open Access | Times Cited: 27
Roles of NRF2 in DNA damage repair
Jiale Li, Chang Xu, Qiang Liu
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1577-1593
Closed Access | Times Cited: 10
Role of Nrf2 in Pancreatic Cancer
Marta Cykowiak, Violetta Krajka‐Kuźniak
Antioxidants (2021) Vol. 11, Iss. 1, pp. 98-98
Open Access | Times Cited: 22
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7963-7963
Open Access | Times Cited: 21
A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase
Miika Mehine, Terhi Ahvenainen, Sara Khamaiseh, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
Wenna Shao, Xinzhao Wang, Zhaoyun Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
In Sickness and in Health: The Oxygen Reactive Species and the Bone
Joana Reis, António Ramos
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 20
Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin
Mariana Camargo Silva Mancini, Ana Paula Morelli, Matheus Brandemarte Severino, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 12, pp. 2079-2092
Closed Access | Times Cited: 13
Nrf2 protein in melanoma progression, as a new means of treatment
Qun Feng, Xiaolin Xu, S Zhang
Pigment Cell & Melanoma Research (2023) Vol. 37, Iss. 2, pp. 247-258
Open Access | Times Cited: 7
NRF1 or NRF2: Emerging Role of Redox Homeostasis on PERK/NRF/Autophagy Mediated Antioxidant in Tumor and Patient Dependent Chemo Sensitivity
Sanaz Dastghaib, Sayed Mohammad Shafiee, Fatemeh Ramezani, et al.
(2024)
Open Access | Times Cited: 2
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC
Mizanur Rahman, Muhammad Mosaraf Hossain, S. M. Didar-Ul Islam, et al.
BMC Molecular and Cell Biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Nitro-fatty acids: promising agents for the development of new cancer therapeutics
Jessica Roos, Georg Manolikakes, Uwe Schlomann, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 11, pp. 1061-1080
Open Access | Times Cited: 2
Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation
Adedeji K. Adebayo, Harikrishna Nakshatri
Cancer Research (2022) Vol. 82, Iss. 23, pp. 4313-4321
Open Access | Times Cited: 9
Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway
Bhagyalakshmi Nair, J. Adithya, Gopika Chandrababu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4398-4413
Open Access | Times Cited: 4
The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End
Manish Kumar
(2024)
Open Access | Times Cited: 1
Insight into the Regulation of Nrf2/Keap 1 Pathway by Flavonoids as an Approach for Treatment of Liver Diseases: A Review
Ruchi Sharma, Chandana Majee, Rupa Mazumder, et al.
Indian Journal of Pharmaceutical Education and Research (2024) Vol. 58, Iss. 1s, pp. s40-s57
Open Access | Times Cited: 1
Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells
Beatriz Matos, Sara Peixoto da Silva, M. Helena Vasconcelos, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells
Dedy Hermansyah, Siti Syarifah, Adi Muradi Muhar, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 319-328
Open Access | Times Cited: 1
Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers
Olawale Razaq Ajuwon, Fleury Augustin Nsole-Biteghe, Jean Delacroix Ndong, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 605-627
Open Access | Times Cited: 1
Epigenetic repression of de novo cysteine synthetases induces intra-cellular accumulation of cysteine in hepatocarcinoma by up-regulating the cystine uptake transporter xCT
Tomoaki Yamauchi, Yumi Okano, Daishu Terada, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Scroll to top